What is the clinical evidence from this study?

Study design: Other. Population: Platelet aggregation. Intervention: Synthetic fibrinoligase inhibitors. Primary outcome: Human platelet aggregation.

January 1, 1972Journal of Medicinal Chemistry

Fibrin-stabilizing factor inhibitors. 4. Action of some synthetic fibrinoligase inhibitors on human platelet aggregation

View Full Paper

Ask AI

Bookmark

Key result

Synthetic fibrinoligase inhibitors show undetermined effects on human platelet aggregation due to missing data.

Population

human platelets

Design

Preclinical

Authors

RLRagnar LundénSwedish Orphan Biovitrum (Sweden)AHAnn Hartkoorn JNJonas NilssonUniversity of Gothenburg

Discussion

Member takes

Implication

Effect cannot be determined from missing data; leaves open whether fibrinoligase inhibitors modulate platelet aggregation.

Structured PICO

Population

human platelets

Intervention

synthetic fibrinoligase inhibitors

Outcome

platelet aggregationsurrogate

Cite This Study

Lundén et al. (1972) studied Platelet aggregation. Synthetic fibrinoligase inhibitors was evaluated on Human platelet aggregation. The effect of synthetic fibrinoligase inhibitors on human platelet aggregation could not be determined because the abstract text is missing.

synapsesocial.com/papers/6aa6e24422b05484233979f0 https://doi.org/10.1021/jm00271a029

View Full Paper

Ask AI

Bookmark

Fibrin-stabilizing factor inhibitors. 4. Action of some synthetic fibrinoligase inhibitors on human platelet aggregation

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Fibrin-stabilizing factor inhibitors. 4. Action of some synthetic fibrinoligase inhibitors on human platelet aggregation

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Also Consider